| pioglitazone / Generic mfg. |
NCT00212290: Insulin Resistance and Central Nervous System (CNS) Function in Type 2 Diabetes |
|
|
| Completed | 4 | 140 | US | pioglitazone, nateglinide, placebo | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Insulin Resistance, Type 2 Diabetes Mellitus | | 12/06 | | |
NCT00203996: Polycystic Ovary Syndrome (PCOS) and Sleep Apnea |
|
|
| Terminated | 4 | 37 | US | continuous positive airway pressure (CPAP), Continuous Positive Airway Pressure, depot leuprolide plus estrogen/progestin replacement, Lupron, pioglitazone, Actos, REM frag, SWS supp | University of Chicago, National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) | Polycystic Ovary Syndrome, Obstructive Sleep Apnea | 06/08 | 06/08 | | |
NCT00579813: Mechanisms Underlying Metabolic Syndrome in Obesity |
|
|
| Completed | 4 | 70 | US | Pioglitazone, Actos | Philip Kern, National Institutes of Health (NIH), National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Metabolic Syndrome, Insulin Resistance, Prediabetes | 01/09 | 01/11 | | |
| Withdrawn | 4 | 120 | Europe | pioglitazone, simvastatin, pioglitazone + simvastatin | University of Leipzig, Institut für Gesundheits- und Praxismanagement GmbH | Glucose Metabolism Disorders | | 05/09 | | |
| Completed | 4 | 43 | US | Pioglitazone, ACTOS, Exenatide, BYETTA, Pioglitazone and Exenatide | The University of Texas Health Science Center at San Antonio | Type 2 Diabetes, Healthy, Impaired Glucose Tolerance | 07/10 | 07/10 | | |
|
